Key statistics dashboard for AEON Biopharma, Inc. (AEON). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc.
Stock Data
| Price | $0.26 |
| Market Cap | $11M |
| Enterprise Value | $10.7M |
| Beta | 0.73 |
| Exchange | AMEX |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.07 |
| Price / Book | -0.85 |
| P/S | 0.00 |
| EV/EBITDA | -0.42 |
| EV/Sales | 0.00 |
| EV/FCF | -0.78 |
| P/FCF | -0.83 |
| Earnings Yield | -420.62% |
| FCF Yield | -120.21% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | 204.18% |
| Return on Assets | -924.25% |
| Return on Invested Capital | 1699.74% |
| Return on Capital Employed | 1387.57% |
Financial Health
| Current Ratio | 0.54 |
| Quick Ratio | 0.54 |
| Cash Ratio | 0.47 |
| Debt / Equity | -0.18 |
| Debt / Assets | 46.95% |
| Net Debt / EBITDA | 0.03 |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -126.80 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | -0.30 |
| Cash per share | 0.07 |
| FCF per share | -0.27 |
| Tangible Book Value per share | -0.30 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 2 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 2 |
| Avg rating (1-5) | 1.00 |
Related companies: ABP · APM · BOLT · CING · CLNN · CLRB · LYRA
Explore sector: Healthcare · Biotechnology
More sections of AEON: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks